Who are we?

BIOALVO designs and develops several applications derived from its technology platform, GPS D2 (Global Platform Screening for Drug Discovery), aimed at the discovery of new drugs. These applications comprise entirely innovative solutions that allow the identification of efficient new drugs with therapeutic potential for unmet medical needs. Using the diverse applications of BIOALVO’s innovative and patented platform GPS D2 we can accelerate and improve the efficiency of the first stages in the discovery of new drugs, reducing significantly the duration time and, consequently, the costs of this process. Coupling this powerful tool with a unique and proprietary source of new leads – PharmaBUG Collection - we foster the discovery of new and more efficient drug candidates to our own and our partners’ portfolio.
BIOALVO's impressive team and expertise in the molecular field, an entirely new discovery strategy and technological approach, allow us to offer the best services at specific phases of the drug development and production process, thus creating added value to our partners (please see partnering).